Jinhong Chang, MD, PhD, was chosen for her outstanding research in molecular virology and antiviral drug discovery. The Baruch S. Blumberg Institute presented the Harvey J. Alter Chair, a newly created honor, to Jinhong Chang, MD, PhD,
Jinhong Chang, MD, PhD, was chosen for her outstanding research in molecular virology and antiviral drug discovery. The Baruch S. Blumberg Institute presented the Harvey J. Alter Chair, a newly created honor, to Jinhong Chang, MD, PhD,
Ju-Tao Guo, MD, globally recognized expert in hepatitis B virology, will lead the Pennsylvania nonprofit research organization.Ju-Tao Guo, MD, a leading expert in hepatitis B virology, was named president of the Baruch S. Blumberg Institute by its
The letter below was sent to U.S. Congressman Guy Reschenthaler and Congresswoman Madeleine Dean on behalf of the Pennsylvania Ad Hoc NIH Funding Advocacy Coalition. A PDF version can be found here. To : Congressman Guy Reschenthaler 2209
Dr. Sofia was responsible for the discovery and early development of sofosbuvir, which became the backbone of many hepatitis C curative therapies.Award-winning scientist Michael J. Sofia, PhD, who discovered the first reliably effective treatment for hepatitis C,
The Hepatitis B Foundation, Baruch S. Blumberg Institute and American Philosophical Society, joined together to celebrate the legacy—and the 100th birthday—of the late Baruch S. Blumberg, MD, DPhil, a Nobel Laureate, on July 29 in Philadelphia.More than
The Hepatitis B Foundation and Baruch S. Blumberg Institute recently presented Nicole E. Geracimos, MD, a Doylestown resident, with the organizations’ first Education Impact Award.Dr. Geracimos was honored at a June 26 event to raise funds for the
Richard G. Pestell, AO, MB, BS, PhD, MD, FRACP, Doctorus Honoris Causa, D. MedSci, FACP, FAAAS, FRSB, MBA, FRCP (Ireland), FRC (London), MAE, distinguished professor at the Blumberg Institute was recently elected to membership of the Hungarian National Academy of
Several Blumberg Institute faculty and research staff recently participated in the 38th International Conference on Antiviral Research (ICAR) hosted by the International Society for Antiviral Research (ISAR), in Las Vegas.Dimitar Gotchev, PhD, presented on “an Oral Hepatitis
Eric J. Brand, a Doylestown-area resident, has been hired as the inaugural Chief People Officer for the Hepatitis B Foundation, Baruch S. Blumberg Institute, and Pennsylvania Biotechnology Center (PABC) after providing human resources support as a consultant
For the third straight year, Louis P. Kassa III, MPA, chief executive officer of the Hepatitis B Foundation, Baruch S. Blumberg Institute and Pennsylvania Biotechnology Center (PABC), has been chosen by the Philadelphia Business Journal for its